Fig. 2From: Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selectionAbsorbed dose to 10 g tumour and organs with physiological uptake by A: DOTA-TATE and B: PSMA-617 at 7400 MBq Lu-177 and various activities of Tb-161, starting at 5300 MBq (DOTATATE, panel A) / 5400 MBq (PSMA, panel B) as the activity with equivalent kidney absorbed dose. The examples given in this figure were chosen to represent some examples from the range between the equivalent kidney absorbed dose and the numerically identical activityBack to article page